Today with Claire Byrne Type 2 Diabetes treatment shake up
Aug 20, 2025
David Strain, an associate professor specializing in cardiometabolic health, discusses the revolutionary changes in treating type 2 diabetes. He emphasizes the importance of personalized care and innovative medications like SGLT2 inhibitors. The conversation highlights proactive treatment approaches to prevent complications and stresses fair access to diabetes medications for marginalized communities. Strain also addresses lifestyle factors contributing to the rise of diabetes, advocating for public health initiatives and minor dietary tweaks for better health.
AI Snips
Chapters
Transcript
Episode notes
Drugs Offer Benefits Beyond Sugar Control
- Newer diabetes drugs provide benefits beyond blood sugar control, like heart protection and weight loss.
- Personalising treatment lets clinicians choose medications for each patient's wider health needs.
Treat Early To Prevent Complications
- Start effective medications earlier to prevent complications rather than waiting to treat them later.
- Use drugs that both control sugar and reduce long-term risks to slow disease progression.
From Reactive Care To Prevention
- The guideline shift means many with type 2 diabetes will get prevention-focused drugs before heart disease or obesity appear.
- This reframes diabetes care from reactive treatment to proactive risk reduction.